Delaware | 001-11462 | 13-3427277 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
1105 North Market Street, Suite 1230, P.O. Box 8985, Wilmington, DE | 19899 | |
(Address of principal executive offices) | (ZIP Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
(a) | Not applicable. | |
(b) | Not applicable. | |
(c) | Not applicable. | |
(d) | Exhibits. |
Exhibit Number | Description of Exhibits | |
99.1
|
Registrants October 27, 2009 press release. |
DELPHI FINANCIAL GROUP, INC. |
||||
/s/ ROBERT ROSENKRANZ | ||||
Robert Rosenkranz | ||||
Chairman of the Board and Chief Executive Officer (Principal Executive Officer) |
||||
Three Months Ended | Nine Months Ended | |||||||||||||||
9/30/2009 | 9/30/2008 | 9/30/2009 | 9/30/2008 | |||||||||||||
Income Statement Data |
||||||||||||||||
Operating earnings (Non-GAAP measure) |
$ | 53,621 | $ | 12,510 | $ | 147,268 | $ | 77,387 | ||||||||
Net realized investment losses, net of taxes |
(32,798 | ) | (21,931 | ) | (64,954 | ) | (38,789 | ) | ||||||||
Loss on redemption of junior subordinated deferrable
interest debentures underlying company-obligated
mandatorily redeemable capital securities issued by
unconsolidated subsidiaries, net of taxes |
| (389 | ) | | (389 | ) | ||||||||||
Net income (loss) (GAAP measure) |
$ | 20,823 | $ | (9,810 | ) | $ | 82,314 | $ | 38,209 | |||||||
Diluted results per share of common stock: |
||||||||||||||||
Operating earnings (Non-GAAP measure) |
$ | 1.00 | $ | 0.26 | $ | 2.91 | $ | 1.57 | ||||||||
Net realized investment losses, net of taxes |
(0.61 | ) | (0.45 | ) | (1.28 | ) | (0.78 | ) | ||||||||
Loss on redemption of junior subordinated deferrable
interest debentures underlying company-obligated
mandatorily redeemable capital securities issued by
unconsolidated subsidiaries, net of taxes |
| (0.01 | ) | | (0.01 | ) | ||||||||||
Net income (loss) (GAAP measure) |
$ | 0.39 | $ | (0.20 | ) | $ | 1.63 | $ | 0.78 | |||||||
Annualized operating return on beginning shareholders equity |
20.4 | % | 4.8 | % | 23.9 | % | 9.0 | % | ||||||||
Annualized net income return on beginning shareholders equity (GAAP measure) |
7.9 | % | -3.8 | % | 13.4 | % | 4.5 | % | ||||||||
9/30/2009 | 12/31/2008 | |||||||||||||||
Balance Sheet Data |
||||||||||||||||
Shareholders equity, excluding accumulated other
comprehensive loss |
$ | 1,379,365 | $ | 1,172,289 | ||||||||||||
Add: Accumulated other comprehensive loss |
(46,303 | ) | (351,710 | ) | ||||||||||||
Shareholders equity (GAAP measure) |
$ | 1,333,062 | $ | 820,579 | ||||||||||||
Diluted book value per share of common stock, excluding
accumulated other comprehensive loss (Non-GAAP measure) |
$ | 24.80 | $ | 24.27 | ||||||||||||
Add: Accumulated other comprehensive loss |
(0.81 | ) | (7.22 | ) | ||||||||||||
Diluted book value per share of common stock (GAAP measure) |
$ | 23.99 | $ | 17.05 | ||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
9/30/2009 | 9/30/2008 | 9/30/2009 | 9/30/2008 | |||||||||||||
Revenue: |
||||||||||||||||
Premium and fee income |
$ | 342,610 | $ | 345,028 | $ | 1,052,776 | $ | 1,028,092 | ||||||||
Net investment income |
88,682 | 19,407 | 243,560 | 112,494 | ||||||||||||
Net realized investment losses: |
||||||||||||||||
Total other than temporary impairment losses |
(73,771 | ) | (28,173 | ) | (137,007 | ) | (52,479 | ) | ||||||||
Less: Portion of other than temporary impairment losses
recognized in other comprehensive income |
21,748 | | 42,467 | | ||||||||||||
Net impairment losses recognized in earnings |
(52,023 | ) | (28,173 | ) | (94,540 | ) | (52,479 | ) | ||||||||
Other net realized investment gains (losses) |
1,564 | (5,567 | ) | (5,389 | ) | (7,196 | ) | |||||||||
(50,459 | ) | (33,740 | ) | (99,929 | ) | (59,675 | ) | |||||||||
Loss on redemption of junior subordinated deferrable
interest debentures underlying company-obligated
mandatorily redeemable capital securities issued by
unconsolidated subsidiaries |
| (598 | ) | | (598 | ) | ||||||||||
380,833 | 330,097 | 1,196,407 | 1,080,313 | |||||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits, claims and interest credited to policyholders |
240,956 | 244,042 | 748,361 | 730,709 | ||||||||||||
Commissions and expenses |
109,680 | 99,824 | 325,076 | 284,400 | ||||||||||||
350,636 | 343,866 | 1,073,437 | 1,015,109 | |||||||||||||
Operating income (loss) |
30,197 | (13,769 | ) | 122,970 | 65,204 | |||||||||||
Interest expense: |
||||||||||||||||
Corporate debt |
3,806 | 4,427 | 11,667 | 12,940 | ||||||||||||
Junior subordinated debentures |
3,247 | 3,240 | 9,728 | 9,726 | ||||||||||||
Junior subordinated deferrable interest debentures underlying
company-obligated mandatorily redeemable capital
securities issued by unconsolidated subsidiaries |
| 177 | | 934 | ||||||||||||
Income tax expense (benefit) |
2,321 | (11,803 | ) | 19,261 | 3,395 | |||||||||||
Net income (loss) |
$ | 20,823 | $ | (9,810 | ) | $ | 82,314 | $ | 38,209 | |||||||
Basic results per share of common stock: |
||||||||||||||||
Net income (loss) |
$ | 0.39 | $ | (0.20 | ) | $ | 1.63 | $ | 0.79 | |||||||
Weighted average shares outstanding |
52,947 | 47,936 | 50,376 | 48,379 | ||||||||||||
Diluted results per share of common stock: |
||||||||||||||||
Net income (loss) |
$ | 0.39 | $ | (0.20 | ) | $ | 1.63 | $ | 0.78 | |||||||
Weighted average shares outstanding |
53,385 | 47,936 | 50,617 | 49,259 | ||||||||||||
Dividends paid per share of common stock |
$ | 0.10 | $ | 0.10 | $ | 0.30 | $ | 0.29 |
9/30/2009 | 12/31/2008 | |||||||
Assets: |
||||||||
Investments: |
||||||||
Fixed maturity securities, available for sale |
$ | 4,608,184 | $ | 3,773,382 | ||||
Short-term investments |
572,802 | 401,620 | ||||||
Other investments |
542,047 | 479,921 | ||||||
5,723,033 | 4,654,923 | |||||||
Cash |
82,269 | 63,837 | ||||||
Cost of business acquired |
244,930 | 264,777 | ||||||
Reinsurance receivables |
378,277 | 376,731 | ||||||
Goodwill |
93,929 | 93,929 | ||||||
Other assets |
320,428 | 409,103 | ||||||
Assets held in separate account |
109,016 | 90,573 | ||||||
Total assets |
$ | 6,951,882 | $ | 5,953,873 | ||||
Liabilities and Shareholders Equity: |
||||||||
Policy liabilities and accruals |
$ | 2,771,885 | $ | 2,574,050 | ||||
Policyholder account balances |
1,452,332 | 1,356,932 | ||||||
Corporate debt |
365,750 | 350,750 | ||||||
Junior subordinated debentures |
175,000 | 175,000 | ||||||
Other liabilities and policyholder funds |
740,539 | 581,954 | ||||||
Liabilities related to separate account |
109,016 | 90,573 | ||||||
Total liabilities |
5,614,522 | 5,129,259 | ||||||
Shareholders equity: |
||||||||
Class A Common Stock |
559 | 489 | ||||||
Class B Common Stock |
60 | 60 | ||||||
Additional paid-in capital |
659,683 | 522,596 | ||||||
Accumulated other comprehensive loss |
(46,303 | ) | (351,710 | ) | ||||
Retained earnings |
916,309 | 846,390 | ||||||
Treasury stock, at cost |
(197,246 | ) | (197,246 | ) | ||||
Total shareholders equity |
1,333,062 | 820,579 | ||||||
Noncontrolling interest |
4,298 | 4,035 | ||||||
Total equity |
1,337,360 | 824,614 | ||||||
Total liabilities and equity |
$ | 6,951,882 | $ | 5,953,873 | ||||
Nine Months Ended | ||||||||
9/30/2009 | 9/30/2008 | |||||||
Operating activities: |
||||||||
Net income |
$ | 82,314 | $ | 38,209 | ||||
Adjustments to reconcile net income to net cash provided
by operating activities: |
||||||||
Change in policy liabilities and policyholder accounts |
225,538 | 194,967 | ||||||
Net change in reinsurance receivables and payables |
(4,613 | ) | 18,901 | |||||
Amortization, principally the cost of business acquired and investments |
38,295 | 46,601 | ||||||
Deferred costs of business acquired |
(97,936 | ) | (94,043 | ) | ||||
Net realized losses on investments |
99,929 | 59,675 | ||||||
Net change in federal income tax liability |
6,632 | (53,654 | ) | |||||
Other |
(14,101 | ) | 56,828 | |||||
Net cash provided by operating activities |
336,058 | 267,484 | ||||||
Investing activities: |
||||||||
Purchases of investments and loans made |
(1,206,214 | ) | (1,012,307 | ) | ||||
Sales of investments and receipts from repayment of loans |
177,957 | 348,569 | ||||||
Maturities of investments |
637,166 | 311,840 | ||||||
Net change in short-term investments |
(171,162 | ) | (158,961 | ) | ||||
Change in deposit in separate account |
4,845 | 10,547 | ||||||
Net cash used by investing activities |
(557,408 | ) | (500,312 | ) | ||||
Financing activities: |
||||||||
Deposits to policyholder accounts |
242,614 | 335,082 | ||||||
Withdrawals from policyholder accounts |
(131,337 | ) | (83,382 | ) | ||||
Borrowings under revolving credit facility |
17,000 | 79,000 | ||||||
Principal payments under revolving credit facility |
(2,000 | ) | (6,000 | ) | ||||
Redemption of junior subordinated deferrable interest debentures
underlying company-obligated mandatorily redeemable capital
securities issued by unconsolidated subsidiaries |
| (20,619 | ) | |||||
Proceeds from issuance of common stock |
121,121 | | ||||||
Acquisition of treasury stock |
| (42,729 | ) | |||||
Cash dividends paid on Common Stock |
(14,767 | ) | (13,715 | ) | ||||
Other financing activities |
7,151 | 3,200 | ||||||
Net cash provided by financing activities |
239,782 | 250,837 | ||||||
Increase in cash |
18,432 | 18,009 | ||||||
Cash at beginning of period |
63,837 | 51,240 | ||||||
Cash at end of period |
$ | 82,269 | $ | 69,249 | ||||